Published in Infect Immun on August 01, 1972
Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol (1996) 6.98
Colonization resistance. Antimicrob Agents Chemother (1994) 4.51
Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun (1983) 3.49
Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun (1983) 2.88
Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog (2010) 2.79
Continuous-flow cultures as in vitro models of the ecology of large intestinal flora. Infect Immun (1983) 2.14
Experimental and mathematical models of Escherichia coli plasmid transfer in vitro and in vivo. Infect Immun (1983) 2.11
Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun (1985) 2.03
Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect Immun (1981) 1.88
Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut (1999) 1.87
Genetic regulatory mechanisms and the ecological niche of Escherichia coli. Proc Natl Acad Sci U S A (1974) 1.84
Distribution of indigenous bacteria in the digestive tract of conventional and gnotobiotic rats. Infect Immun (1975) 1.80
Microbiology of bacterial translocation in humans. Gut (1998) 1.75
Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infect Immun (1985) 1.74
Inhibition of Escherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminated mice. Infect Immun (1980) 1.65
Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice. Infect Immun (1986) 1.58
Inhibition of translocation of viable Escherichia coli from the gastrointestinal tract of mice by bacterial antagonism. Infect Immun (1979) 1.48
Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother (1987) 1.47
Microbial ecological basis of infant botulism as studied with germfree mice. Infect Immun (1979) 1.44
Antagonism among the normal anaerobic bacteria of the mouse gastrointestinal tract determined by immunofluorescence. Appl Environ Microbiol (1978) 1.41
Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infect Immun (1977) 1.36
Role of volatile fatty acids in development of the cecal microflora in broiler chickens during growth. Appl Environ Microbiol (2000) 1.32
Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans. Antimicrob Agents Chemother (1987) 1.24
Benefit and mischief from commensal bacteria. J Clin Pathol (1973) 1.16
Volatile fatty acids and aerobic flora in the gastrointestinal tract of mice under various conditions. Infect Immun (1979) 1.09
Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia. Infect Immun (1991) 1.06
Effects of fecal microorganisms and their chloroform-resistant variants derived from mice, rats, and humans on immunological and physiological characteristics of the intestines of ex-germfree mice. Infect Immun (1994) 1.03
Interaction between Escherichia coli and Shigella flexneri in the digestive tract of "gnotobiotic" mice. Infect Immun (1974) 1.00
Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model. Infect Immun (1993) 0.92
Escherichia coli pathotypes occupy distinct niches in the mouse intestine. Infect Immun (2014) 0.89
Lactobacilli as effectors of host functions: no influence on the activities of enzymes in enterocytes of mice. Appl Environ Microbiol (1987) 0.87
Effectiveness of palladium chloride for the isolation of anaerobes. J Clin Microbiol (1976) 0.86
Intestinal microflora in rats: isolation and characterization of strictly anaerobic bacteria requiring long-chain fatty acids. Appl Environ Microbiol (1976) 0.81
Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. BMC Microbiol (2016) 0.81
Prevention of hospital-acquired pneumonia in critically ill patients. Antimicrob Agents Chemother (1993) 0.80
Elevated fecal Candida counts in patients with antibiotic-associated diarrhea: role of soluble fecal substances. Clin Diagn Lab Immunol (2003) 0.77
Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure. Appl Microbiol (1969) 14.62
The gastrointestinal epithelium and its autochthonous bacterial flora. J Exp Med (1968) 10.84
Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut. Br J Exp Pathol (1963) 6.60
STUDIES ON THE STABILITY OF THE NORMAL HUMAN FECAL FLORA. J Bacteriol (1962) 4.53
The anaerobic bacterial flora of the mouse cecum. J Exp Med (1970) 4.52
THE RUMEN BACTERIA AND PROTOZOA. Annu Rev Microbiol (1964) 4.17
The effect of diet on the fecal bacterial flora of mice and on their resistance to infection. J Exp Med (1962) 3.82
RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. II. FACTORS RESPONSIBLE FOR ITS LOSS FOLLOWING STREPTOMYCIN TREATMENT. J Exp Med (1964) 3.80
ECOLOGICAL MECHANISM CONTROLLING GROWTH OF ESCHERICHIA COLI IN CONTINUOUS FLOW CULTURES AND IN THE MOUSE INTESTINE. J Infect Dis (1964) 2.97
The Influence of Milk and Carbohydrate Feeding on the Character of the Intestinal Flora: IV. Diet versus Bacterial Implantation. J Bacteriol (1917) 2.96
In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism. J Infect Dis (1962) 2.85
Efficiency of various intestinal bacteria in assuming normal functions of enteric flora after association with germ-free mice. Infect Immun (1970) 2.51
Persistence of individual strains of Escherichia coli in man and dog under varying conditions. J Bacteriol (1956) 2.47
Interaction in the germfree mouse intestine of colicinogenic and colicin-sensitive microorganisms. Proc Soc Exp Biol Med (1969) 2.09
[Stability of coli flora of the healthy human. 1. The occurrence of permanent and changing types]. Arch Hyg Bakteriol (1969) 1.49
Enteric pathogen--normal flora interactions. Am J Clin Nutr (1970) 1.47
Automatic determination of weak organic acids by partition column chromatography and indicator titration. Anal Chem (1966) 1.06
Cholic acid inhibition of intestinal bacteria. Am J Clin Nutr (1970) 0.94
Mixed bacterial infections in relation to antibiotic activities. IV. Shigella-Escherichia coli infections. J Immunol (1960) 0.91
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure. Appl Microbiol (1969) 14.62
Use of anaerobic glove boxes for the cultivation of strictly anaerobic bacteria. Am J Clin Nutr (1972) 11.38
Adhesive properties of Vibrio cholerae: nature of the interaction with isolated rabbit brush border membranes and human erythrocytes. Infect Immun (1976) 6.59
Adhesive properties of Vibrio cholerae: adhesion to isolated rabbit brush border membranes and hemagglutinating activity. Infect Immun (1976) 5.86
Adhesive properties of Vibrio cholerae: nature of the interaction with intact mucosal surfaces. Infect Immun (1976) 5.36
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Protection against enteric bacterial infection by secretory IgA antibodies. J Immunol (1973) 4.92
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34
Improved isolation of anaerobic bacteria from the mouse cecum by maintaining continuous strict anaerobiosis. Proc Soc Exp Biol Med (1967) 4.03
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation (1983) 4.01
Effect of the normal microbial flora on gastrointestinal motility. Proc Soc Exp Biol Med (1967) 3.64
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (1982) 3.50
Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun (1983) 3.49
Parameters affecting the association of vibrios with the intestinal surface in experimental cholera. Infect Immun (1972) 3.10
Effect of the normal microbial flora on the resistance of the small intestine to infection. J Bacteriol (1966) 2.94
Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun (1983) 2.88
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun (1981) 2.76
Efficiency of various intestinal bacteria in assuming normal functions of enteric flora after association with germ-free mice. Infect Immun (1970) 2.51
Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res (1984) 2.44
Clindamycin-induced enterocolitis in hamsters. J Infect Dis (1978) 2.43
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun (1981) 2.39
Mechanisms of association of bacteria with mucosal surfaces. Ciba Found Symp (1981) 2.29
Continuous-flow cultures as in vitro models of the ecology of large intestinal flora. Infect Immun (1983) 2.14
Experimental and mathematical models of Escherichia coli plasmid transfer in vitro and in vivo. Infect Immun (1983) 2.11
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: chemotactic responses of Vibrio cholerae and description of motile nonchemotactic mutants. Infect Immun (1981) 1.97
The role of chemotaxis in the ecology of bacterial pathogens of mucosal surfaces. Nature (1977) 1.89
Effect of chemotaxis on the interaction of cholera vibrios with intestinal mucosa. Am J Clin Nutr (1979) 1.85
Interactions between mechanisms controlling the intestinal microflora. Am J Clin Nutr (1974) 1.74
Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice. Infect Immun (1986) 1.58
Aortic cobwebs: an anatomic marker identifying the false lumen in aortic dissection--imaging and pathologic correlation. Radiology (1994) 1.44
Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis (1985) 1.44
The protective effect of vancomycin on clindamycin-induced colitis in hamsters. Johns Hopkins Med J (1977) 1.42
Sudden death in a 55-year-old woman with systemic lupus erythematosus. Circulation (1998) 1.40
Early spontaneous recovery of left ventricular function in patients with myocarditis. Ital Heart J (2000) 1.39
Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut (1980) 1.37
Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infect Immun (1977) 1.36
Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J Infect Dis (1986) 1.34
Adhesion and chemotaxis as determinants of bacterial association with mucosal surfaces. Adv Exp Med Biol (1978) 1.32
Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J (1986) 1.31
Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis (1982) 1.31
Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. J Infect Dis (1977) 1.25
Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures. Infect Immun (1989) 1.21
Source and protective function of coproantibodies in intestinal disease. Am J Clin Nutr (1972) 1.20
Synergism between ecologic and immunologic control mechanisms of intestinal flora. J Infect Dis (1974) 1.19
Inhibition of Clostridium perfringens by an antibiotic substance produced by Bacillus licheniformis in the digestive tract of gnotobiotic mice: effect on other bacteria from the digestive tract. Antimicrob Agents Chemother (1976) 1.17
Availability of locally synthesized and systemic antibodies in the intestine. Infect Immun (1972) 1.10
Diet and the equilibrium between bacteria and yeast implanted in gnotobiotic rats. Am J Clin Nutr (1972) 1.07
The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase. Circ Res (1985) 1.05
Lethal toxicity of Mycoplasma fermentans for mice. J Infect Dis (1972) 1.04
Effect of cholera toxin on water and ion fluxes in the canine bowel. Gastroenterology (1968) 1.03
Pathogenetic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice. J Immunol (1976) 1.01
Lipid storage disease in a Siamese cat. J Am Vet Med Assoc (1970) 1.01
Models for studying the role of bacterial attachment in virulence and pathogenesis. Rev Infect Dis (1983) 1.01
13C nuclear magnetic resonance detection of interactions of serine hydroxymethyltransferase with C1-tetrahydrofolate synthase and glycine decarboxylase complex activities in Arabidopsis. Plant Physiol (1996) 1.01
Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J (1987) 1.00
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation (1986) 0.99
Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals. Circulation (1986) 0.98
Microbial effects on mucosal structure and function. Am J Clin Nutr (1977) 0.97
Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog. Circulation (1977) 0.97
Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest (1991) 0.97
Nutritional muscular dystrophy and neonatal mortality in a rabbit breeding colony. J Am Vet Med Assoc (1970) 0.97
High intensity focused ultrasound effect on cardiac tissues: potential for clinical application. Echocardiography (2000) 0.94
Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost (1993) 0.93
Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). J Pharmacol Exp Ther (1976) 0.93
Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine. J Cardiovasc Pharmacol (1986) 0.93
Effects of sulfanilamide and methotrexate on 13C fluxes through the glycine decarboxylase/serine hydroxymethyltransferase enzyme system in arabidopsis. Plant Physiol (1998) 0.92
Histopathology of serum-transmitted immune polioencephalomyelitis in C58 mice. Proc Soc Exp Biol Med (1973) 0.91
Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J Am Coll Cardiol (1992) 0.88
Possible effects of foreign DNA on pathogenic potential and intestinal proliferation of Escherichia coli. J Infect Dis (1978) 0.88
Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog. Circulation (1981) 0.87
Creation of reentry tears in aortic dissection by means of percutaneous balloon fenestration: gross anatomic and histologic considerations. J Vasc Interv Radiol (1993) 0.86
Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease. J Lab Clin Med (1989) 0.85
Platelet depletion in experimental myocardial infarction. Basic Res Cardiol (1985) 0.85
Metabolic activation and detoxification of bromobenzene leading to cytotoxicity. J Pharmacol Exp Ther (1980) 0.85
Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma. Cancer Chemother Pharmacol (1993) 0.85
Conservative management of bilateral massive edema of the ovary. A case report. J Reprod Med (1993) 0.85
Effect of gastrointestinal flora on body temperature of rats and mice. Am J Physiol (1990) 0.84
Delayed pentobarbital therapy of acute focal cerebral ischemia. Stroke (1978) 0.83
FV-1 restriction of age-dependent paralytic lactic dehydrogenase virus infection. Virology (1982) 0.83
The dissected aorta: part II. Differentiation of the true from the false lumen with intravascular US. Radiology (1997) 0.83
Scintigraphic characterization of amyloid cardiomyopathy. Clin Nucl Med (1985) 0.82
Production of an antibiotic substance by Bacillus licheniformis within the digestive tract of gnotobiotic mice. Antimicrob Agents Chemother (1978) 0.81
Aortobronchial fistula 13 years following repair of aortic transection. Chest (1994) 0.81
Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration. Circulation (1983) 0.81
Cytomegalovirus cholangitis in a homosexual man with acquired immune deficiency syndrome. Am J Gastroenterol (1986) 0.80
Cytoimmunologic monitoring and heart transplantation. J Heart Transplant (1989) 0.80
Physiologic assessment of the four commonly performed endorectal pullthroughs. Ann Surg (1987) 0.80
Niche required for inducing quiescent stem cells. Cold Spring Harb Symp Quant Biol (2008) 0.80
Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis. Lab Invest (1981) 0.79
Shock-wave thrombus ablation, a new method for noninvasive mechanical thrombolysis. Am J Cardiol (1992) 0.79
Ibuprofen-mediated infarct size reduction: effects on regional myocardial function in canine myocardial infarction in canine myocardial infarction. Am J Cardiol (1982) 0.79
Characterization of transplantable myelomonocytic leukemia WEHI-3B in syngeneic BALB/c mice. Proc Soc Exp Biol Med (1978) 0.78
Malignant fibrous histiocytoma of the heart presenting as unilateral pulmonary thromboembolism and infarct. Hum Pathol (1985) 0.78
Neurological involvement in mice after infection with a cold-adapted herpes simplex type 2 virus. Infect Immun (1982) 0.78
Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy)benzaldehyde semicarbazone after oral dosing to rats. Pharmazie (1999) 0.78
Spontaneous neoplasms in aging gerbillinae. Lab Anim Sci (1972) 0.78